Pramlintide
Exploratory Study to Evaluate Various Pharmacodynamic Effects of Subcutaneously Infused or Injected Pramlintide in Obese Subjects
AstraZeneca · Phase 2 · Completed · Enrollment 184
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Pramlintide acetate (AC137) | n/r | n/r | n/r | n/r |
Not shown
- Pramlintide acetate (AC137): endpoint not reported